CBIH — Cannabis Bioscience International Holdings Income Statement
0.000.00%
Last trade - 00:00- $5.81m
- $6.22m
- $0.30m
Annual income statement for Cannabis Bioscience International Holdings, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.762 | 0.215 | 0.317 | 0.249 | 0.303 |
| Cost of Revenue | |||||
| Gross Profit | 0.762 | 0.168 | 0.223 | 0.203 | 0.263 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.921 | 1.05 | 1.26 | 0.735 | 0.701 |
| Operating Profit | -0.159 | -0.834 | -0.942 | -0.486 | -0.398 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.159 | -0.885 | -1.03 | -0.651 | -0.549 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.159 | -0.885 | -1.03 | -0.651 | -0.549 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.159 | -0.885 | -1.03 | -0.651 | -0.549 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.159 | -0.885 | -1.03 | -0.651 | -0.549 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | -0 | -0 | -0 | -0 |